Severe hypercalcemia due to teriparatide

Osteoporosis that is by far the most common metabolic bone disease, has been defined as a skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. Anabolic therapy with teriparatide, recombinant human parathyroid hormone (PTH 1-34), stimula...

Descripción completa

Detalles Bibliográficos
Autores principales: Karatoprak, Cumali, Kayatas, Kadir, Kilicaslan, Hanifi, Yolbas, Servet, Yazimci, Nurhan Aliye, Gümüskemer, Tolga, Demirtunç, Refik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326929/
https://www.ncbi.nlm.nih.gov/pubmed/22529492
http://dx.doi.org/10.4103/0253-7613.93869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326929/
https://www.ncbi.nlm.nih.gov/pubmed/22529492
http://dx.doi.org/10.4103/0253-7613.93869

Ejemplares similares